1. Home
  2. GNTY vs VALN Comparison

GNTY vs VALN Comparison

Compare GNTY & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTY
  • VALN
  • Stock Information
  • Founded
  • GNTY 1913
  • VALN 2012
  • Country
  • GNTY United States
  • VALN France
  • Employees
  • GNTY N/A
  • VALN N/A
  • Industry
  • GNTY Major Banks
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GNTY Finance
  • VALN Health Care
  • Exchange
  • GNTY Nasdaq
  • VALN Nasdaq
  • Market Cap
  • GNTY 434.5M
  • VALN 510.7M
  • IPO Year
  • GNTY 2017
  • VALN 2021
  • Fundamental
  • Price
  • GNTY $41.69
  • VALN $6.38
  • Analyst Decision
  • GNTY Buy
  • VALN Strong Buy
  • Analyst Count
  • GNTY 2
  • VALN 3
  • Target Price
  • GNTY $41.00
  • VALN $15.33
  • AVG Volume (30 Days)
  • GNTY 27.0K
  • VALN 12.7K
  • Earning Date
  • GNTY 04-21-2025
  • VALN 05-07-2025
  • Dividend Yield
  • GNTY 2.42%
  • VALN N/A
  • EPS Growth
  • GNTY 18.89
  • VALN N/A
  • EPS
  • GNTY 2.91
  • VALN N/A
  • Revenue
  • GNTY $123,780,000.00
  • VALN $201,099,222.00
  • Revenue This Year
  • GNTY $10.99
  • VALN $17.98
  • Revenue Next Year
  • GNTY $4.68
  • VALN $26.61
  • P/E Ratio
  • GNTY $14.08
  • VALN N/A
  • Revenue Growth
  • GNTY 4.44
  • VALN 21.64
  • 52 Week Low
  • GNTY $27.01
  • VALN $3.62
  • 52 Week High
  • GNTY $42.95
  • VALN $9.50
  • Technical
  • Relative Strength Index (RSI)
  • GNTY 65.06
  • VALN 45.06
  • Support Level
  • GNTY $40.14
  • VALN $6.25
  • Resistance Level
  • GNTY $40.32
  • VALN $6.55
  • Average True Range (ATR)
  • GNTY 1.04
  • VALN 0.32
  • MACD
  • GNTY 0.22
  • VALN -0.02
  • Stochastic Oscillator
  • GNTY 92.39
  • VALN 20.35

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: